VKH
TRAW icon

Virtu KCG Holdings’s Traws Pharma TRAW Stock Holding History

Virtu KCG Holdings’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2
Closed -$36K – 3586
2017
Q1 		$36K Hold
2
– – ﹤0.01% 2897
2016
Q4 		$25K Buy
+2
New +$29.7K ﹤0.01% 3213
2016
Q2 		– Hold
0
– -$8K – 3393
2016
Q1 		– Sell
-1
Closed -$31.7K – 2663
2015
Q4 		$34K Hold
1
– – ﹤0.01% 3226
2015
Q3 		$59K Buy
+1
New +$107K ﹤0.01% 2969
2014
Q4 		– Hold
0
– -$48K – 4308
2014
Q3 		– Hold
0
– – – 3356
2014
Q1 		– Hold
0
– -$143K – 4171
2013
Q4 		– Hold
0
– – – 3294

Other funds holding TRAW

TCP
Tyndall Capital Partners New York $452K AUM 26.52% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HFM
Hartford Financial Management Hartford, Connecticut $392M AUM 21.9% 1-Year Est. Return

Virtu KCG Holdings's TRAW Position: Q2 2017 in Review

Virtu KCG Holdings sold out of Traws Pharma (TRAW) in Q2 2017, closing a stake of 2 shares — an estimated $36K sold.

Virtu KCG Holdings first reported a position in TRAW in Q3 2015 and held it in 4 quarters. The position peaked at $59K in Q3 2015. 9 funds tracked by Wall St. Rank hold TRAW as of Q2 2017.

  • Virtu KCG Holdings reported no remaining Traws Pharma position as of Q2 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 2 Traws Pharma shares in Q2 2017, an estimated $36K.
  • Virtu KCG Holdings first reported a position in Traws Pharma in Q3 2015 and held it in 4 quarters.
  • Virtu KCG Holdings's Traws Pharma position peaked at $59K in Q3 2015.
  • 9 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.